S100鈣結合蛋白A9(S100A9)真核蛋白
Eukaryotic S100 Calcium Binding Protein A9 (S100A9)
MRP14; MIF; 60B8AG; CFAG; NIF; CAGB; CGLB; L1AG; P14; Calgranulin B; Migration inhibitory factor-related protein 14; Calprotectin L1H subunit; Leukocyte L1 complex heavy chain
- 編號UEPB793Hu61
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源真核表達
- 宿主293F cell
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜, 分泌, 細胞質
- 預測分子量44.1kDa
- 實際分子量44kDa(差異分析請參閱說明書)
- 片段與標簽Thr2~Pro114 with N-terminal His Tag and C-terminal Fc Region of Human IgG1
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點6.1
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 480 ¥ 1200 ¥ 2400 ¥ 7200 ¥ 18000
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| UEPB793Hu61 | S100鈣結合蛋白A9(S100A9)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPB793Hu01 | S100鈣結合蛋白A9(S100A9)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB793Hu01 | S100鈣結合蛋白A9(S100A9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB793Hu01 | S100鈣結合蛋白A9(S100A9)多克隆抗體 | WB; IHC; ICC/IF |
| ULAB793Hu81 | S100鈣結合蛋白A9(S100A9)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| ULAB793Hu71 | S100鈣結合蛋白A9(S100A9)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| UMAB793Hu29 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB |
| UMAB793Hu22 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB; IHC |
| UMAB793Hu21 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB; IHC |
| UMAB793Hu23 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB |
| UMAB793Hu27 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB; IHC; ICC/IF |
| UMAB793Hu24 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB; IHC |
| UMAB793Hu25 | S100鈣結合蛋白A9(S100A9)單克隆抗體 | WB; IHC |
| ULAB793Hu82 | S100鈣結合蛋白A9(S100A9)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| ULAB793Hu72 | S100鈣結合蛋白A9(S100A9)單克隆抗體(生物素標記) | WB |
| USEB793Hu | S100鈣結合蛋白A9(S100A9)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB793Hu | S100鈣結合蛋白A9(S100A9)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSB793Hu01 | S100鈣結合蛋白A9(S100A9)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| J. Proteome Res. | Differential Proteomic Analysis Distinguishes Tissue Repair Biomarker Signatures in Wound Exudates Obtained from Normal Healing and Chronic Wounds [Pubmed: source] |
| Biochemical and Biophysical Research Communications | High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice [ScienceDirect: S0006291X1200352X] |
| PLoS One. | Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis [PubMed: 23029420] |
| Mainz | Identifizierung neuer potentieller Biomarker für das Kolonkarzinom sowie dessen Vorstufen [Info:Source] |
| PLOS ONE | Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking [Pubmed:25036363] |
| the faseb journal | Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation [PubMed: 25934702] |
| Sci Rep.? | S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine [pmc:PMC4810364] |
| Journal?of?Alzheimer's?Disease | Proteomics?Analysis?of?Blood?Serums?from?Alzheimer's?Disease?Patients?Using?iTRAQ?LabelingTechnology. [pubmed:27911324] |
| International journal of molecular sciences | Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds. [pubmed:28672877] |
| Gastroenterology | Tu1938-Micronutrients Assessment in Patients with Cirrhosis [10.1016:S0016-5085(18)33544-3] |
| Gastroenterology | Tu1942-PI3K/AKT-Mediated Upregulation of C7 Inhibits Colorectal Cancer Proliferation and Metastasis [10.1016:S0016-5085(18)33544-5] |
| Journal of Biological Chemistry | Signaling between pancreatic β-cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation [Pubmed:29496993] |
| Cancer?Management and?Research | The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo [Pubmed:29497331] |
| European?review for?medical?and pharmacological?sciences | S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα. [Pubmed:29949169] |
| Estudio de células inmunosupresoras y biomarcadores circulantes en carcinoma renal [] | |
| Lung | Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis [Pubmed: 31115649] |
| 中國醫(yī)藥導報 | 降鈣素原, 超敏C 反應蛋白, 紅細胞沉降率及S100A9 對肺結核合并肺部細菌感染的影響 [] |
| scandinavian journal of clinical & laboratory investigation | Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study [Pubmed: 31856598] |
| PLoS One | Adverse reproductive effects of S100A9 on bovine sperm and early embryonic development in vitro [Pubmed: 31945120] |
| Sci Rep | Overexpression of S100A9 in tumor stroma contribute to immune evasion of NK/T cell lymphoma and predict poor response rate [34045609] |
| university of copenhagen | Adjunctive S100A8/A9 Immunomodulation Hinders Cipro fl oxacin Resistance in [] |
留言咨詢
